Compound Detail
CHEMBL4576555
T3-CLK-N Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
CN1CCN(C(=O)C(C)(C)c2ccc(C(=O)Nc3cn4cc(-c5cc(C(C)(C)C)cc(C(C)(C)C)c5)ccc4n3)cc2)CC1
Basic Information
| ChEMBL ID | CHEMBL4576555 |
| Name | T3-CLK-N |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | BNTGVINQADRYBE-UHFFFAOYSA-N |
22
Targets
59
Activities
1
Assay Types
0
PK Parameters
20
Publications
1
Known Names
Molecular Properties
593.8
MW (Da)
6.90
ALogP
5
HBA
1
HBD
70.0
PSA (Ų)
0.27
QED
2
Ro5 Violations
5
Rot. Bonds
Drug Information
| Molecule Type | Unknown |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
Ki 59 meas. best 6.39
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Sigma intracellular receptor 2 CHEMBL4105907 | Ki | 6.39 | 6.385 | 407.4 | 2 |
| Sigma non-opioid intracellular receptor 1 CHEMBL287 | Ki | 6.13 | 6.11 | 741.3 | 3 |
| Kappa-type opioid receptor CHEMBL237 | Ki | 6.01 | 6.0033 | 977.2 | 3 |
| 5-hydroxytryptamine receptor 2C CHEMBL225 | Ki | 5.98 | 5.9733 | 1047.1 | 3 |
| D(1A) dopamine receptor CHEMBL2056 | Ki | 5.89 | 5.85 | 1288.2 | 3 |
| 5-hydroxytryptamine receptor 2A CHEMBL224 | Ki | 5.88 | 5.84 | 1318.3 | 3 |
| Histamine H1 receptor CHEMBL231 | Ki | 5.88 | 5.7733 | 1318.3 | 3 |
| Alpha-1A adrenergic receptor CHEMBL229 | Ki | 5.87 | 5.8367 | 1349.0 | 3 |
| Alpha-1D adrenergic receptor CHEMBL223 | Ki | 5.84 | 5.84 | 1445.4 | 2 |
| Alpha-2B adrenergic receptor CHEMBL1942 | Ki | 5.79 | 5.7833 | 1621.8 | 3 |
| Histamine H2 receptor CHEMBL1941 | Ki | 5.79 | 5.775 | 1621.8 | 2 |
| D(3) dopamine receptor CHEMBL234 | Ki | 5.72 | 5.6733 | 1905.5 | 3 |
| Muscarinic acetylcholine receptor M1 CHEMBL216 | Ki | 5.71 | 5.695 | 1949.8 | 2 |
| 5-hydroxytryptamine receptor 1B CHEMBL1898 | Ki | 5.7 | 5.68 | 1995.3 | 2 |
| 5-hydroxytryptamine receptor 1A CHEMBL214 | Ki | 5.66 | 5.6167 | 2181.0 | 3 |
| 5-hydroxytryptamine receptor 5A CHEMBL3426 | Ki | 5.65 | 5.6167 | 2238.7 | 3 |
| D(2) dopamine receptor CHEMBL217 | Ki | 5.63 | 5.5833 | 2344.2 | 3 |
| Alpha-2A adrenergic receptor CHEMBL1867 | Ki | 5.58 | 5.58 | 2630.3 | 3 |
| 5-hydroxytryptamine receptor 1D CHEMBL1983 | Ki | 5.55 | 5.53 | 2818.4 | 2 |
| 5-hydroxytryptamine receptor 1E CHEMBL2182 | Ki | 5.46 | 5.4533 | 3467.4 | 3 |
| Mu-type opioid receptor CHEMBL233 | Ki | 5.4 | 5.38 | 3981.1 | 3 |
| Alpha-1B adrenergic receptor CHEMBL232 | Ki | 5.27 | 5.265 | 5370.3 | 2 |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| - | 10.6019/CHEMBL4689842 | HEK-293T | 261 |
| - | 10.6019/CHEMBL4689842 | U2OS | 258 |
| - | 10.6019/CHEMBL4689842 | Fibroblast | 255 |
| - | 10.6019/CHEMBL5724558 | Colon cancer organoid | 12 |
| - | 10.6019/CHEMBL5674860 | Colon cancer organoid | 12 |
| - | 10.6019/CHEMBL5724696 | U2OS | 8 |
| - | 10.6019/CHEMBL5608141 | Colon cancer organoid | 6 |
| - | 10.1158/2159-8290.CD-23-0050 | Colon cancer organoid | 5 |
| - | 10.6019/CHEMBL4507307 | D(2) dopamine receptor | 3 |
| - | 10.6019/CHEMBL4507307 | 5-hydroxytryptamine receptor 1E | 3 |
| - | 10.6019/CHEMBL4507307 | Mu-type opioid receptor | 3 |
| - | 10.6019/CHEMBL4507307 | 5-hydroxytryptamine receptor 2A | 3 |
| - | 10.6019/CHEMBL4507307 | Kappa-type opioid receptor | 3 |
| - | 10.6019/CHEMBL4507307 | Alpha-2B adrenergic receptor | 3 |
| - | 10.6019/CHEMBL4507307 | Sigma non-opioid intracellular receptor 1 | 3 |
| - | 10.6019/CHEMBL4507307 | Sigma intracellular receptor 2 | 3 |
| - | 10.6019/CHEMBL4507307 | Alpha-1A adrenergic receptor | 3 |
| - | 10.6019/CHEMBL4507307 | Alpha-2C adrenergic receptor | 3 |
| - | 10.6019/CHEMBL4507307 | D(1A) dopamine receptor | 3 |
| - | 10.6019/CHEMBL4507307 | Alpha-2A adrenergic receptor | 3 |
Data from ChEMBL 36 via Core Engine